{"data":{"id":"us-al/ala.-code-22-5d-6","jurisdiction":"us-al","citation":"Ala. Code § 22-5D-6","heading":"Effect on License or Certification.","body":"A licensing board or disciplinary subcommittee shall not issue a letter of concern or similar form of reprimand, nor revoke, fail to renew, suspend, or take any action against a health care provider’s license issued under Title 34, based solely on the health care provider’s recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device. An entity responsible for Medicare certification shall not reprimand or take action against a health care provider’s Medicare certification based solely on the health care provider’s recommendation that a patient have access to an investigational drug, biological product, or device.","path":["Title 22 Health, Mental Health, and Environmental Control.","Title 1 Health and Environmental Control Generally.","Chapter 5D Gabe Griffin Right to Try Act."],"source_url":"https://alison.legislature.state.al.us/code-of-alabama?section=22-5D-6","current_through":"Act 2026-611","vintage":"","retrieved_at":"2026-09-03T14:01:53Z","sha256":"4c181dcdea72f77a23ed724d268d2c947360890be082af94565521041536a1fa","source_id":"us-al","stale":false,"prev":"us-al/ala.-code-22-5d-5","next":"us-al/ala.-code-22-5d-7"},"notice":"GroundRules: Original legal text. Not legal advice."}